Juvenile Hemochromatosis: Rheumatic Manifestations of 2 Sisters Responding to Deferasirox Treatment. A Case Series and Literature Review
Jubran Alqanatish,1– 3 Banan Alsowailmi,1 Haneen Alfarhan,1 Albandari Alhamzah,1 Talal Alharbi1,2,4 1King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh 14611, Saudi Arabia; 2King Abdullah International Medical Research Center (KAIMRC), Riyadh 14611, Saudi Arabia; 3Dep...
Guardado en:
Autores principales: | Alqanatish J, Alsowailmi B, Alfarhan H, Alhamzah A, Alharbi T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/904c7b033eef4d73b8f9ac2b76556c5d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Possible roles of the hereditary hemochromatosis protein, HFE, in regulating cellular iron homeostasis
por: ENNS,CAROLINE A
Publicado: (2006) -
Hereditary hemochromatosis: An opportunity for gene therapy
por: EZQUER,FERNANDO, et al.
Publicado: (2006) -
Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009) -
The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
por: Reimold AM
Publicado: (2012) -
Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseases
por: Perez Alamino R, et al.
Publicado: (2012)